Phase I/II trial of the anti-idiotypic monoclonal antibody ACA125 in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 5018-5018 ◽  
Author(s):  
F. Hilpert ◽  
P. Harter ◽  
S. Reinartz ◽  
J. Sehouli ◽  
S. Loibl ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Fallopian Tube ◽  
Peritoneal Cancer

scholarly journals Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

2006 ◽  
Vol 12 (18) ◽  
pp. 5503-5510 ◽  
Author(s):  
Paul Sabbatini ◽  
Jakob Dupont ◽  
Carol Aghajanian ◽  
Felicia Derosa ◽  
Elizabeth Poynor ◽  
...  
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Phase I Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer

Phase I/Ib clinical and immunologic assessment of immunotherapeutic vaccine, DPX-Survivac in women with ovarian, Fallopian tube, or peritoneal cancer (OC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 5555-5555 ◽  
Author(s):  
Michelle Wilson ◽  
Jeannine A. Villella ◽  
Neil Lorne Berinstein ◽  
Jennifer Brown ◽  
Stephanie Lheureux ◽  
...  
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Peritoneal Cancer

Phase I Study of Abagovomab in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

2007 ◽  
Vol 13 (13) ◽  
pp. 4026.1-4026
Author(s):  
Birgit C. Schultes ◽  
L. Mary Smith ◽  
Christopher F. Nicodemus
Keyword(s):  
Phase I ◽  
Fallopian Tube ◽  
Phase I Study ◽  
Primary Peritoneal Cancer ◽  
Peritoneal Cancer
Sign in / Sign up

Export Citation Format

Share Document